| 注册
首页|期刊导航|中药材|藏药多血康胶囊治疗HAPC的网络药理学机制研究

藏药多血康胶囊治疗HAPC的网络药理学机制研究

王静 赵可惠 唐策 吕秀梅 降佣四朗 魏志成 张艺

中药材2017,Vol.40Issue(7):1687-1694,8.
中药材2017,Vol.40Issue(7):1687-1694,8.DOI:10.13863/j.issn1001-4454.2017.07.041

藏药多血康胶囊治疗HAPC的网络药理学机制研究

Network Pharmacology of Tibetan Medicine Duoxuekang Capsule in Treatment of High Altitude Polycythemia

王静 1赵可惠 1唐策 1吕秀梅 1降佣四朗 1魏志成 1张艺1

作者信息

  • 1. 成都中医药大学民族医药学院,四川成都611137
  • 折叠

摘要

Abstract

Objective:To explore the molecular mechanism of Tibetan medicine Duoxuekang capsule in the treatment of high altitude polycythemia(HAPC) by using network pharmacology.Methods:Firstly the chemical constituents of four flavor herbs (Phyllanthi Fructus,Rhodiolae Crenulatae Radix et Rhizoma,Hippophae Fructus,Zingiberis Rhizome) in Duoxuekang capsule were respectively screened by literature search and TCMSP database,then predictive analysis targets by PharmMapper server.Potential targets were submitted to MAS 3.0 database for target annotation and analysis.And pathway analysis would be performed with KEGG database.Finally,Cytoscape software was used to construct the “compounds-targets targets-pathway” network diagram of Duoxuekang capsule in treatment of HAPC.Results:Virtual experiments predicted 176 chemical constituents of Duoxuekang capsule,which involved 393 action targets.Finally 64 targets and 90 pathways related to Duoxuekang capsule anti-hypoxia,anti-oxidation and blood stasis was got.Conclusion:Duoxuekang capsule in treatment of HAPC is mainly through the regulation of the immune system,inflammatory sydtem,cardiovascular system and metabolic pathways,and may be involved in enhancing immune,improve blood coagulation and inflammatory reaction,regulate metabolism and other aspects.

关键词

网络药理学/藏药/多血康胶囊/HAPC/作用机制

Key words

Network pharmacology/Tibetan medicine/Duoxuekang capsule/High altitude polycythemia/Mechanism

分类

医药卫生

引用本文复制引用

王静,赵可惠,唐策,吕秀梅,降佣四朗,魏志成,张艺..藏药多血康胶囊治疗HAPC的网络药理学机制研究[J].中药材,2017,40(7):1687-1694,8.

基金项目

国家自然科学基金(81603394,81503362) (81603394,81503362)

四川省教育厅省属高校科研创新团队建设计划(11TD004) (11TD004)

成都中医药大学科技发展基金(CGPY1503,030018002) (CGPY1503,030018002)

中药材

OA北大核心CSTPCD

1001-4454

访问量0
|
下载量0
段落导航相关论文